Difference Strain Ratio Ultrasound Elastography Between Benign and Malignant Peripheral Lung Lesions
NCT ID: NCT05752227
Last Updated: 2023-03-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
120 participants
OBSERVATIONAL
2022-06-01
2023-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of Ultrasound Elastography in Differentiation of Peripheral Lung Lesions
NCT05759390
The Effectiveness and Safety of Ultrasound Elastography Guided Pleural Biopsy in the Differential Diagnosis of Benign and Malignant Pleural Effusion
NCT05781659
The Role of Endobronchial Ultrasound Elastography in the Diagnosis of Mediastinal Lesions
NCT02724059
Significance of Ultrasound Elastography in Lymph Node
NCT03391557
Study on The Value of Endobronchial Ultrasound Elastography in The Diagnosis of Thoracic Lesions
NCT02755506
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
benign lung lesions
Patient who were diagnosed with peripheral lung lesions including consolidation, atelectasis, or cavitation
Transthoracic biopsy
Us guided transthoracic biopsy
CT chest
Computed tomography
malignant lung lesions
patients diagnosed with malignant lung lesions
Transthoracic biopsy
Us guided transthoracic biopsy
CT chest
Computed tomography
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transthoracic biopsy
Us guided transthoracic biopsy
CT chest
Computed tomography
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Clinical instability to reach the final diagnosis.
3. Inaccessibility by ultrasound.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alexandria University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmed F Abouelnour, Masters
Role: PRINCIPAL_INVESTIGATOR
Alexandrian University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ahmed Farag Abouelnour
Alexandria, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0201692
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.